DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Kelly WK, O’Connor O A, Krug LM. et al.
Phase I Study of an Oral Histone Deacetylase Inhibitor, Suberoylanilide Hydroxamic Acid, in Patients With Advanced Cancer.
J Clin Oncol 2005; 16: 16-
We do not assume any responsibility for the contents of the web pages of other providers.